Advanced Nonhematologic Malignancies
5 clinical trials · Condition
◉ Watch Advanced Nonhematologic Malignancies
| Record | Firm | Date |
|---|---|---|
| A Study MLN2480 in Combination With MLN0128 or Alisertib, or Paclitaxel, or Cetuximab, or Irinotecan in Adult Participants With Advanced Nonhematologic Malignancies (NCT02327169) | Millennium Pharmaceuticals, Inc. | 2015-01-14 |
| Study of TAK-733 in Combination With Alisertib in Adult Patients With Advanced Nonhematologic Malignancies (NCT01613261) | Millennium Pharmaceuticals, Inc. | 2013-08-01 |
| A Safety and Pharmacokinetic Study of TAK-228 in Combination With TAK-117 in Adult Participants With Advanced Nonhematologic Malignancies (NCT01899053) | Millennium Pharmaceuticals, Inc. | 2013-06-28 |
| A Study of TAK-441 in Adult Patients With Advanced Nonhematologic Malignancies (NCT01204073) | Millennium Pharmaceuticals, Inc. | 2010-10-01 |
| Study of MLN4924 in Adult Patients With Nonhematologic Malignancies (NCT00677170) | Millennium Pharmaceuticals, Inc. | 2008-04-01 |
Track Advanced Nonhematologic Malignancies automatically
Every clearance here is in the API, with alerts when new ones post.